Vestmark Advisory Solutions’s Guardant Health GH Stock Holding History

Vestmark Advisory Solutions’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.92M	Buy	19,451 +2,275	+13%	+$247K	0.03%	558
2026 Q1	$1.59M	Sell	17,176 -11,144	-39%	-$1.12M	0.02%	719
2025 Q4	$2.89M	Buy	+28,320	New	+$2.53M	0.04%	469
2023 Q3	–	Sell	-11,940	Closed	-$427K	–	593
2023 Q2	$427K	Sell	11,940 -238	-2%	-$6.83K	0.02%	620
2023 Q1	$285K	Buy	12,178 +615	+5%	+$17.6K	0.01%	716
2022 Q4	$315K	Sell	11,563 -745	-6%	-$34.1K	0.02%	668
2022 Q3	$663K	Buy	12,308 +1,139	+10%	+$58.5K	0.04%	478
2022 Q2	$451K	Sell	11,169 -882	-7%	-$43.7K	0.03%	565
2022 Q1	$798K	Sell	12,051 -357	-3%	-$24.4K	0.05%	419
2021 Q4	$1.24M	Sell	12,408 -191	-2%	-$19.8K	0.07%	321
2021 Q3	$1.57M	Buy	12,599 +26	+0.2%	+$3.09K	0.11%	245
2021 Q2	$1.56M	Buy	12,573 +1,484	+13%	+$200K	0.11%	229
2021 Q1	$1.69M	Sell	11,089 -178	-2%	-$26.9K	0.15%	193
2020 Q4	$1.45M	Sell	11,267 -217	-2%	-$25K	0.16%	173
2020 Q3	$1.28M	Sell	11,484 -19	-0.2%	-$1.74K	0.17%	170
2020 Q2	$933K	Sell	11,503 -651	-5%	-$52.5K	0.14%	202
2020 Q1	$846K	Buy	+12,154	New	+$933K	0.17%	177

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vestmark Advisory Solutions's GH Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Guardant Health (GH) stake by 13% in Q2 2026, buying an estimated $247K and bringing the position to 19,451 shares worth $2.92M. The position accounts for 0.03% of the portfolio, ranked #558.

Vestmark Advisory Solutions first reported a position in GH in Q1 2020 and has held it in 17 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Vestmark Advisory Solutions held 19,451 shares of Guardant Health worth $2.92M as of Q2 2026.
Vestmark Advisory Solutions bought 2,275 Guardant Health shares in Q2 2026, an estimated $247K.
Guardant Health made up 0.03% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #558 holding.
Vestmark Advisory Solutions first reported a position in Guardant Health in Q1 2020 and has held it in 17 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.